Engineering a conditionally active cetuximab prodrug via affibody-based paratope masking.

Mestre Borras A, Mehari H, Bitzios A, Zelepukin I, Ud-Din M, Xu T, Li S, Orlova A, Tolmachev V, Ståhl S, Vorobyeva A, Löfblom J

Open source

DOI: 10.1186/s13036-026-00705-1
Published: 2026 Jun 8
Container: Journal of biological engineering
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1186/s13036-026-00705-1,
  title = {Engineering a conditionally active cetuximab prodrug via affibody-based paratope masking.},
  author = {Mestre Borras A and Mehari H and Bitzios A and Zelepukin I and Ud-Din M and Xu T and Li S and Orlova A and Tolmachev V and Ståhl S and Vorobyeva A and Löfblom J},
  year = {2026},
  journal = {Journal of biological engineering},
  doi = {10.1186/s13036-026-00705-1},
  url = {https://doi.org/10.1186/s13036-026-00705-1}
}

RIS

TY  - JOUR
TI  - Engineering a conditionally active cetuximab prodrug via affibody-based paratope masking.
AU  - Mestre Borras A
AU  - Mehari H
AU  - Bitzios A
AU  - Zelepukin I
AU  - Ud-Din M
AU  - Xu T
AU  - Li S
AU  - Orlova A
AU  - Tolmachev V
AU  - Ståhl S
AU  - Vorobyeva A
AU  - Löfblom J
PY  - 2026
JO  - Journal of biological engineering
DO  - 10.1186/s13036-026-00705-1
UR  - https://doi.org/10.1186/s13036-026-00705-1
ER  -

APA

A, M. B., H, M., A, B., I, Z., M, U., T, X., S, L., A, O., V, T., S, S., A, V., & J, L. (2026). Engineering a conditionally active cetuximab prodrug via affibody-based paratope masking.. Journal of biological engineering. https://doi.org/10.1186/s13036-026-00705-1

Source records

pubmed · retrieved 2026-09-25T17:54:59.901Z